Functional analysis of two PLA2G2A variants associated with secretory phospholipase A2-IIA levels

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Exeter, Holly J ^a   Folkersen, Lasse ^b   Palmen, Jutta ^a   Franco Cereceda, Anders ^b   Cooper, Jackie A ^a   Kalea, Anastasia Z ^a   van't Hooft, Ferdinand ^b   Eriksson, Per ^b   Humphries, Steve E ^a   Talmud, Philippa J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; RNA; SECRETORY PHOSPHOLIPASE A2;

ALLELE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EXON; EXON SKIPPING; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; HUMAN TISSUE; LIVER; LYMPHOCYTE; NUCLEOTIDE SEQUENCE; PLA2G2A GENE;

ALLELES; ALTERNATIVE SPLICING; BINDING SITES; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENOTYPE; GROUP II PHOSPHOLIPASES A2; HUMANS; LIVER; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROTEIN BINDING;

ANIMALIA;

EID: 84864018497     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041139     Document Type: Article

References (25)

1. Pruzanski W, Keystone EC, Sternby B, Bombardier C, Snow KM, et al. (1988) Serum phospholipase A2 correlates with disease activity in rheumatoid arthritis. J Rheumatol 15: 1351-1355.
2. Oorni K, Kovanen PT, (2009) Lipoprotein modification by secretory phospholipase A(2) enzymes contributes to the initiation and progression of atherosclerosis. Curr Opin Lipidol 20: 421-427.
3. Henderson WR Jr, Oslund RC, Bollinger JG, Ye X, Tien YT, et al. (2011) Blockade of human group X secreted phospholipase A2 (GX-sPLA2)-induced airway inflammation and hyperresponsiveness in a mouse asthma model by a selective GX-sPLA2 inhibitor. J Biol Chem 286: 28049-28055.
4. Jonsson-Rylander AC, Lundin S, Rosengren B, Pettersson C, Hurt-Camejo E, (2008) Role of secretory phospholipases in atherogenesis. Curr Atheroscler Rep 10: 252-259.
5. Leonarduzzi G, Gamba P, Gargiulo S, Biasi F, Poli G, (2011) Inflammation-related gene expression by lipid oxidation-derived products in the progression of atherosclerosis. Free Radic Biol Med.
6. Lambeau G, Gelb MH, (2008) Biochemistry and physiology of mammalian secreted phospholipases A2. Annu Rev Biochem 77: 495-520.
7. Hurt-Camejo E, Camejo G, Sartipy P, (2000) Phospholipase A2 and small, dense low-density lipoprotein. Curr Opin Lipidol 11: 465-471.
8. Webb NR, Bostrom MA, Szilvassy SJ, van der Westhuyzen DR, Daugherty A, et al. (2003) Macrophage-expressed group IIA secretory phospholipase A2 increases atherosclerotic lesion formation in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 23: 263-268.
9. Mallat Z, Benessiano J, Simon T, Ederhy S, Sebella-Arguelles C, et al. (2007) Circulating secretory phospholipase A2 activity and risk of incident coronary events in healthy men and women: the EPIC-Norfolk study. Arterioscler Thromb Vasc Biol 27: 1177-1183.
10. Mallat Z, Steg PG, Benessiano J, Tanguy ML, Fox KA, et al. (2005) Circulating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromes. J Am Coll Cardiol 46: 1249-1257.
11. Boekholdt SM, Keller TT, Wareham NJ, Luben R, Bingham SA, et al. (2005) Serum levels of type II secretory phospholipase A2 and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study. Arterioscler Thromb Vasc Biol 25: 839-846.
12. Mallat Z, Lambeau G, Tedgui A, (2010) Lipoprotein-associated and secreted phospholipases A in cardiovascular disease: roles as biological effectors and biomarkers. Circulation 122: 2183-2200.
13. Wootton PT, Drenos F, Cooper JA, Thompson SR, Stephens JW, et al. (2006) Tagging-SNP haplotype analysis of the secretory PLA2IIa gene PLA2G2A shows strong association with serum levels of sPLA2IIa: results from the UDACS study. Hum Mol Genet 15: 355-361.
14. Fan Q, Paradon M, Salvat C, Bereziat G, Olivier JL, (1997) C/EBP factor suppression of inhibition of type II secreted phospholipase A2 promoter in HepG2 cells: possible role of single-strand binding proteins. Mol Cell Biol 17: 4238-4248.
15. Tsai NP, Lin YL, Wei LN, (2009) MicroRNA mir-346 targets the 5′-untranslated region of receptor-interacting protein 140 (RIP140) mRNA and up-regulates its protein expression. Biochem J 424: 411-418.
16. Henke JI, Goergen D, Zheng J, Song Y, Schuttler CG, et al. (2008) microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J 27: 3300-3310.
17. Lu M, Shyy JY, (2006) Sterol regulatory element-binding protein 1 is negatively modulated by PKA phosphorylation. Am J Physiol Cell Physiol 290: C1477-1486.
18. Touqui L, Alaoui-El-Azher M, (2001) Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases. Curr Mol Med 1: 739-754.
19. Ponugoti B, Kim DH, Xiao Z, Smith Z, Miao J, et al. (2010) SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. J Biol Chem 285: 33959-33970.
20. Giandomenico V, Simonsson M, Gronroos E, Ericsson J, (2003) Coactivator-dependent acetylation stabilizes members of the SREBP family of transcription factors. Mol Cell Biol 23: 2587-2599.
21. Trousson A, Bernard S, Petit PX, Liere P, Pianos A, et al. (2009) 25-hydroxycholesterol provokes oligodendrocyte cell line apoptosis and stimulates the secreted phospholipase A2 type IIA via LXR beta and PXR. J Neurochem 109: 945-958.
22. Hingorani A, Humphries S, (2005) Nature's randomised trials. Lancet 366: 1906-1908.
23. Smith AJ, Humphries SE, (2009) Characterization of DNA-binding proteins using multiplexed competitor EMSA. J Mol Biol 385: 714-717.
24. Folkersen L, van't Hooft F, Chernogubova E, Agardh HE, Hansson GK, et al. (2010) Association of genetic risk variants with expression of proximal genes identifies novel susceptibility genes for cardiovascular disease. Circ Cardiovasc Genet 3: 365-373.
25. Folkersen L, Diez D, Wheelock CE, Haeggstrom JZ, Goto S, et al. (2009) GeneRegionScan: a Bioconductor package for probe-level analysis of specific, small regions of the genome. Bioinformatics 25: 1978-1979.